27.12.2012 Views

Genetics of Diabetes

Genetics of Diabetes

Genetics of Diabetes

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Genetics</strong> <strong>of</strong> <strong>Diabetes</strong><br />

Melissa Fries, MD<br />

Clinical Geneticist/Obstetrician-<br />

Gynecology


In your Jeans or your Genes?


Definition <strong>of</strong> genetics<br />

Study <strong>of</strong> inherited characteristics<br />

� Viewed in context <strong>of</strong> an individual and his/her<br />

family<br />

� Infinitely broad scope<br />

� Molecular genetics and the nature <strong>of</strong> genes<br />

� Medical genetics and the nature <strong>of</strong> illness<br />

� Clinical genetics and the diagnosis <strong>of</strong> disorders


Classic Medical <strong>Genetics</strong><br />

� Single gene disorders:<br />

� Over 3000<br />

� Often expressed in the pediatric population<br />

� Resources:<br />

� www.genetests.org<br />

� On-line Mendelian Inheritance in Man<br />

� www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM<br />

� New Focus in <strong>Genetics</strong>: Complex common<br />

disease


Single gene abnormalities<br />

� Usually identified through a recognizable<br />

abnormality<br />

� “Treasure your exceptions”<br />

� Easier to recognize a visible abnormality than<br />

an abnormal gene<br />

� Inheritance patterns <strong>of</strong> these abnormalities is<br />

a clue to their genetic make-up and valuable<br />

to the family


Family inheritance patterns<br />

� Mendelian (single gene) disorders<br />

� Autosomal dominant<br />

� Autosomal recessive<br />

� X-linked<br />

� Multi-factorial disorders<br />

� Mitochondrial disorders<br />

� Abnormalities <strong>of</strong> mitochondrial DNA


Multifactorial inheritance<br />

� Condition is related to the interaction <strong>of</strong><br />

multiple genes and environmental factors<br />

� No predictable pattern <strong>of</strong> recurrence<br />

� Recurrence risks based on empiric data <strong>of</strong><br />

population studies<br />

� Usually is the square root <strong>of</strong> the population<br />

frequency--3-4%<br />

� Most likely involved in common, complex<br />

diseases such as diabetes


Multifactorial disorders<br />

� Higher recurrence risks if<br />

� more family members are affected<br />

� affected person is <strong>of</strong> the less commonly affected<br />

sex<br />

� more severe initial condition<br />

� Reduced recurrence risk with<br />

� more distant relationship (negligible in 3degree<br />

relatives)<br />

� Concerns to recognize both genetic<br />

predisposition AND environmental triggers


<strong>Diabetes</strong> mellitus<br />

� Extremely common disorder <strong>of</strong> glucose<br />

metabolism related to a failure <strong>of</strong> adequate<br />

insulin production<br />

� T1D: autoimmune destruction <strong>of</strong> beta cells<br />

� T2D: Impaired insulin effectiveness along<br />

with failure to produce adequate insulin<br />

� Affects over 18 million people in the US


Permutt,<br />

2005


Epidemiology <strong>of</strong> DM<br />

� Lifetime risk for development <strong>of</strong> DM<br />

� 33% for males<br />

� 39% for females<br />

� 53% for Hispanic females<br />

� Related also to age<br />

� 10 times more common >65 than


<strong>Genetics</strong> <strong>of</strong> T1D (10% <strong>of</strong> DM)<br />

� Disease requires predisposing genetic<br />

background and<br />

� Interaction with other environmental factors<br />

� End result: T cell mediated destruction <strong>of</strong> beta<br />

cells<br />

� Most cases are sporadic<br />

� No standard Mendelian pattern <strong>of</strong> inheritance<br />

� Susceptibility to disease, rather than disease itself<br />

appears to be inherited


Autoimmune triggers: T-cells<br />

may directly target insulin<br />

� Kent, et al Nature 435, 2005:<br />

� Examined T cells from pancreatic draining lymph<br />

nodes in diabetic patients with DR4 susceptability<br />

allele<br />

� Specific clone <strong>of</strong> T cells which recognized the<br />

insulin A1-15 epitope<br />

� Strongly supports autoimmune effect from<br />

stimulated T-cells


Autoimmune Triggers: GAD<br />

� Glutamic acid decarboxylase 1/2 (GAD 1 and<br />

2)<br />

� Catalyzes gamma aminobutyric acid from Lglutamic<br />

acid<br />

� Found to act as autoantigen in T1D as well as stiff<br />

person syndrome<br />

� Gene is at 10p11.23<br />

� 2 common isotypes: GAD65 and 67 in brain and<br />

pancreatic islet cells


Autoimmune effects<br />

� GAD 65<br />

� Shares 24 AA segment with P2-C protein <strong>of</strong><br />

coxsackie virus<br />

� 17 viruses identified with some homology to<br />

various segments <strong>of</strong> GAD65<br />

� De Aizpurua, 1992: anti-GAD found in most<br />

subjects with pre-clinical IDDM<br />

� Antibodies against common viruses may also<br />

target GAD<br />

� End result: gradual beta islet cell failure


Genetic predisposition: HLA<br />

genotypes<br />

� DR and DQ loci on chromosome 6p major<br />

genetic influences for T1D<br />

� DR1,3,4,8, and 2(16) increase susceptibility<br />

� DR 5 and 2(15) provide protection<br />

� DQ 0602 provides dominant protection against<br />

T1D<br />

� Strong susceptibility to narcolepsy


HLA genes<br />

Chromosome<br />

6p


HLA subtypes and<br />

susceptibility<br />

� Exaggerated susceptibility to T1D in<br />

DR3/DR4 heterozygotes<br />

� Appears to relate to production <strong>of</strong> unique<br />

hybrid molecules which lead to altered<br />

functional immune response in DR4 subtypes


Norwegian studies<br />

� One <strong>of</strong> the highest world frequencies <strong>of</strong> T1D<br />

� Ronningen, et al: <strong>Diabetes</strong>, 1997<br />

� Specific HLA genotype at high risk<br />

� DR4-DQ8/DR3-DQ2<br />

� Confers RR <strong>of</strong> 20 for T1D development<br />

� Absolute risk <strong>of</strong> 7% by age 15<br />

� In Norway, tested in neonatal screening<br />

� 2.1% <strong>of</strong> newborns carry this genotype


MIDIA study: Environmental<br />

Triggers <strong>of</strong> Type 1 <strong>Diabetes</strong><br />

� Rasmussen et al, <strong>Diabetes</strong> Care, 2009<br />

� Followed 1003 newborns screen positive (in 46,939<br />

newborns screened) for high risk genotype<br />

� 885 tested serially for autoantibodies to insulin, GAD, and<br />

insulinoma-associated protein 2<br />

� Followed for 6 years<br />

� 36 developed islet autoimmunity (4%)<br />

� 10 developed diabetes<br />

� Maternal BMI >30kg/m 2 and wt gain <strong>of</strong> >15 kg in pregnancy<br />

increased risk for islet autoimmunity in <strong>of</strong>fspring by 2-3fold<br />

� ?Increased maternal/fetal glucose may increase fetal insulin<br />

production and growth <strong>of</strong> islet cells


PANDA study<br />

� Prospective Assessment in Newborns for<br />

<strong>Diabetes</strong> Autoimmunity<br />

� NIH Observational study (still recruiting)<br />

� Initiated in early 2000<br />

� U <strong>of</strong> FL and Georgia<br />

� Evaluate risk for development <strong>of</strong> T1D<br />

� Measure genetic risk factors (HLA)<br />

� Autoimmunity markers<br />

� Family history


PANDA study<br />

� No diabetes outcome data reported yet<br />

� 3 published reports on psychosocial factors<br />

related to the study<br />

� Genet Med, 2003: 73% <strong>of</strong> mothers recall infant’s<br />

diabetes risk accurately<br />

� <strong>Diabetes</strong> Care, 2005: No overall increase in maternal<br />

depression regarding infant’s diabetes risk<br />

� Increased depression if mother is <strong>of</strong> ethnic minority, limited<br />

education, or with post partum depresssion<br />

� <strong>Diabetes</strong> Care, 2005: 67% <strong>of</strong> mothers <strong>of</strong> at risk<br />

infants reported 1 or more diabetes prevention<br />

behaviors


Single nucleotide polymorphism<br />

(SNP) studies<br />

� European Consortium for IDDM Genome<br />

studies<br />

� Identified susceptibility loci on 2p, 5q, 16p<br />

� Suggest non-HLA genes also involved<br />

� Interaction between HLA and non-HLA loci may be<br />

etiologic<br />

� No clear pattern at this time


Family risk for T1D(Schatz and Winter,<br />

Current opinions in Pediatrics, 1995; 7:459-465)<br />

General population .2%<br />

Any 1 st degree relative 5%<br />

Sibling: no HLA shared 1-2%<br />

1 HLA haplotype shared 5-7%<br />

2 HLA haplotypes shared 16-17 %<br />

Both HLA haplotypes 20-25%<br />

DR3/DR4<br />

Monozygotic twins 33%


Other genes involved<br />

� CTLA4 cytoxic T-lymphocyte associated<br />

protein 4<br />

� PTPN22 Protein tyrosine phosphate nonreceptor<br />

type 22<br />

� INS (Variable number <strong>of</strong> tandem repeats)<br />

� Permutt, J Clin Invest, Vol 115(6), June 2005:<br />

1431-1439


T2D (90% <strong>of</strong> DM)<br />

� Increase in frequency follows increase in<br />

obesity, urbanization, and wealth<br />

� “Thrifty genotype” postulated<br />

� Genetic advantage <strong>of</strong> accelerated fat deposition in<br />

time <strong>of</strong> restricted calories<br />

� Disadvantage in time <strong>of</strong> unrestricted calories<br />

� “Thrifty phenotype” (Barker hypothesis)<br />

� Malnourishment (IUGR) leads to impaired beta cell<br />

development, insulin resistance, and predisposition to<br />

adult diabetes and metabolic syndrome


<strong>Genetics</strong> <strong>of</strong> T2D<br />

� Still very poorly understood<br />

� May relate to susceptibility issues to obesity as<br />

well as insulin resistance<br />

� Combined inherited/environmental features<br />

not well understood


Triggers: Obesity<br />

� Sargeant, NIH, 2003: 38% <strong>of</strong> the excess risk<br />

associated with a family history <strong>of</strong> diabetes<br />

could be avoided if BMI was not allowed to<br />

be greater than 30kg/m 2 .<br />

� However, relatives <strong>of</strong> non-obese T2D may<br />

have greater risk for disease development<br />

� Implies possible greater genetic burden if disease<br />

development in absence <strong>of</strong> obesity


Obese<br />

Not Obese<br />

Goldfine, Proc Nat Aca Sci, 2003<br />

Fm Hx <strong>Diabetes</strong><br />

<strong>Diabetes</strong><br />

development:<br />

16.7/1000<br />

person years<br />

<strong>Diabetes</strong><br />

development:<br />

8.8/1000 person<br />

years<br />

No family Hx <strong>of</strong><br />

<strong>Diabetes</strong><br />

<strong>Diabetes</strong><br />

development:<br />

1.8/1000 person<br />

years<br />

<strong>Diabetes</strong><br />

development:<br />

1.6/1000 person<br />

years


Possible Genes associating<br />

with T2D<br />

� Genes involved in insulin secretion<br />

� ABCC8 (sulfonylurea receptor) and KCNJ11<br />

� Components <strong>of</strong> the K ATP channel on beta cells<br />

� Uncoupling protein UCP2<br />

� Mitochondrially encoded NADH dehydrogenase<br />

� Variants will be inherited only maternally<br />

� Transcription factor 7-like 2 (TCF7L2)


Possible Genes associating<br />

with T2D<br />

� Insulin and Insulin signaling genes<br />

� INS insulin gene<br />

� Insulin receptor (INSR)<br />

� Insulin-like growth factor IGF2(adjacent to INS gene)<br />

� Insulin receptor substrate IRS1<br />

� Note: All studied changes are related to<br />

polymorphisms—variations in sequence not<br />

associated with protein malformation or absence but<br />

which may vary protein efficiency or adaptation<br />

� Defects in insulin expression or insulin receptor expression<br />

would probably be lethal.


Possible Genes associating<br />

with T2D<br />

� Lipid and glucose metabolism genes<br />

� Peroxisome proliferative activated receptor<br />

gamma (PPARG)<br />

� Transcription factor which regulates adipocyte<br />

development as well as lipid and glucose metabolism<br />

� Common variant: Pro12Ala (substitutes alanine for<br />

proline) which alters binding affinity<br />

� Confers moderately increased risk for T2D<br />

� May also influence obesity


Possible Genes associating<br />

with T2D<br />

� Peroxisome proliferative activated receptor-gamma<br />

coactivator 1-alpha (PPARGC1A)<br />

� Beta 3 adrenergic receptor<br />

� Glucose transporter 1<br />

� Adiponectin<br />

� Forkhead box C2 (FOXC2)<br />

� Mannose-binding lectin (protein C)2<br />

� Calpain 10<br />

� Plasminogen activator inhibitor type 1


MODY-maturity onset diabetes<br />

<strong>of</strong> the young<br />

� Early onset T2D less than age 25 in non-obese<br />

patients<br />

� Defects in insulin secretion<br />

� AD inheritance pattern, 2-5% <strong>of</strong> T2D<br />

� Different subtypes related to different genes<br />

� HNF4alpha (hepatocyte nuclear factor): 5%<br />

� GCK (glucokinase) 12.5%<br />

� HNF1A(hepatocyte nuclear factor 1a): 65%<br />

� IPF1<br />

� HNF1B<br />

� NEU-ROD1<br />

� Genetic testing available


Genetests.org search for genetic testing for <strong>Diabetes</strong> mellitus<br />

Search Result for Disease Name Containing 'diabetes mellitus'<br />

ABCC8-Related Transient Neonatal <strong>Diabetes</strong> Mellitus 2<br />

<strong>Diabetes</strong> Mellitus, 6q24-Related Transient Neonatal<br />

<strong>Diabetes</strong> Mellitus, Insulin-Resistant, with Acanthosis Nigricans<br />

<strong>Diabetes</strong> Mellitus, KCNJ11-Related Transient Neonatal<br />

<strong>Diabetes</strong> Mellitus, Neonatal, with Congenital Hypothyroidism<br />

<strong>Diabetes</strong> Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension<br />

<strong>Diabetes</strong> Mellitus, Permanent Neonatal, with Cerebellar Agenesis<br />

Maturity-Onset <strong>Diabetes</strong> <strong>of</strong> the Young Type 1 [<strong>Diabetes</strong> Mellitus, MODY Type 1]<br />

More Links<br />

HNF4A-Related Maturity-Onset <strong>Diabetes</strong> <strong>of</strong> the Young Type 1 [HNF4A-Related <strong>Diabetes</strong> Mellitus, MODY Type<br />

1]<br />

More Links<br />

INS-Related Maturity-Onset <strong>Diabetes</strong> <strong>of</strong> the Young Type 1 [INS-Related <strong>Diabetes</strong> Mellitus, MODY Type<br />

1]<br />

More Links<br />

Maturity-Onset <strong>Diabetes</strong> <strong>of</strong> the Young Type 2 [<strong>Diabetes</strong> Mellitus, MODY Type 2]<br />

Links<br />

Maturity-Onset <strong>Diabetes</strong> <strong>of</strong> the Young Type 3 [<strong>Diabetes</strong> Mellitus, MODY Type 3]<br />

Maturity-Onset <strong>Diabetes</strong> <strong>of</strong> the Young Type 4 [<strong>Diabetes</strong> Mellitus, MODY Type 4]<br />

Maturity-Onset <strong>Diabetes</strong> <strong>of</strong> the Young Type 6 [<strong>Diabetes</strong> Mellitus, MODY Type 6]<br />

Multiple Epiphyseal Dysplasia with Early-Onset <strong>Diabetes</strong> Mellitus<br />

Permanent Neonatal <strong>Diabetes</strong> Mellitus<br />

ABCC8-Related Permanent Neonatal <strong>Diabetes</strong> Mellitus<br />

GCK-Related Permanent Neonatal <strong>Diabetes</strong> Mellitus<br />

INS-Related Permanent Neonatal <strong>Diabetes</strong> Mellitus<br />

KCNJ11-Related Permanent Neonatal <strong>Diabetes</strong> Mellitus<br />

PDX1-Related Permanent Neonatal <strong>Diabetes</strong> Mellitus<br />

Pineal Hyperplasia, Insulin-Resistant <strong>Diabetes</strong> Mellitus, and Somatic Abnormalities<br />

Renal Cysts and <strong>Diabetes</strong> Syndrome [<strong>Diabetes</strong> Mellitus, MODY Type 5]<br />

Items 1 - 16 <strong>of</strong> 16<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More Links<br />

More


Family Risk for T2D (Groop, J Int Med 1997:<br />

241:95-101)<br />

Offspring <strong>of</strong> one parent with<br />

T2D<br />

Offspring <strong>of</strong> two parents with<br />

T2D<br />

Siblings <strong>of</strong> individuals with<br />

T2D<br />

Monozygotic twins<br />

concordancy<br />

40% lifetime risk<br />

80-100% lifetime risk<br />

35% lifetime risk<br />

70-80%*<br />

May be 100% if index<br />

case has disease onset<br />

after age 45


<strong>Genetics</strong> <strong>of</strong> Diabetic<br />

nephropathy<br />

� Diabetic nephropathy is a subtype, affecting<br />

1/3 <strong>of</strong> those with T1D after 40 years<br />

� Familial aggregation seen in those with diabetic<br />

nephropathy<br />

� Black ethnicity and early onset <strong>of</strong> ESRD also clustered<br />

� Genome wide linkage scans survey genome<br />

for regions coinherited with a trait<br />

� Linkage found to 7q35,3q26,9q22,20p12


Special inheritance pattern in<br />

diabetes<br />

� Mitochondrial effects


Mitochondrial Inheritance<br />

� Occurs from mutation in mitochondrial DNA<br />

� circular double stranded DNA found in multiple<br />

copies in each mitochondrion<br />

� Mitochondria are tiny energy producing<br />

organelles <strong>of</strong> the cell<br />

� 1000’s in each cell<br />

� Passed in the cytoplasm <strong>of</strong> the ovum<br />

� Exclusive maternal transmission<br />

� If mother is affected, disease is passed to all her<br />

<strong>of</strong>fspring


Mitochondrial Inheritance<br />

� Displays heteroplasmy<br />

� Different mitochondria may or may not have the<br />

mutation<br />

� Severity <strong>of</strong> disease is proportional to the relative<br />

proportions <strong>of</strong> normal and abnormal mitochondrial<br />

DNA<br />

� Affected males cannot transmit the disease<br />

� Affected females transmit to all their children


Mitochondrial disease in<br />

diabetes<br />

� MIDD: Maternally inherited diabetes and<br />

deafness<br />

� Mutation in mitochondrial DNA (3243tRNA leu)<br />

� Same mutation associated with MELAS<br />

� Mitochondrial myopathy, encephalopathy, lactic<br />

acidosis, and stroke-like episodes<br />

� Usually not obese, with deafness preceding DM<br />

� Appears to lead to defect in insulin release


Gestational diabetes<br />

� Permutt, 2005<br />

� Gestational diabetes is “state <strong>of</strong> glucose<br />

intolerance in pregnancy . . . With major<br />

implications for subsequent development <strong>of</strong> T2D<br />

as pregnancy serves as an ‘environmental<br />

stressor’ that reveals a genetic predisposition.”


Genetic susceptibility to GDM<br />

� Any parental history <strong>of</strong> T2D diabetes<br />

increases risk for GDM 2.3x<br />

� Mothers with a diabetic sibling have 8.4 fold<br />

higher risk <strong>of</strong> GDM than women with no<br />

diabetic siblings<br />

� Lifetime risk for T2D after having GDM is 15-<br />

60%


What is the heritability for<br />

GDM?<br />

� May relate to epigenetic changes in the in-utero environment<br />

leading to future predisposition<br />

� Epigenetic changes: Changes in gene activation or suppression<br />

by methylation <strong>of</strong> DNA or deacetylation <strong>of</strong> histones—not DNA<br />

sequence changes<br />

� 2 older studies showing that GDM is more frequent in the<br />

mothers <strong>of</strong> women who themselves later develop GDM<br />

� Also greater likelihood for GDM in women whose mothers, not<br />

fathers have T2D<br />

� No paternal or maternal influence seen in T1D parents for GDM<br />

� Implication that prenatal exposure to diabetic intrauterine<br />

environment may lead to increased predisposition to GDM in<br />

adult pregnant state


Effects <strong>of</strong> Gestational <strong>Diabetes</strong><br />

on <strong>of</strong>fspring<br />

� J MatFetNeonatal Med, 2008: Vohr,et al<br />

� Pediatrics, 2004, Boney et al<br />

� Development <strong>of</strong> metabolic syndrome in children<br />

related to<br />

� Maternal gestational diabetes mellitus<br />

� Maternal glycemia in the 3 rd trimester<br />

� Maternal obesity<br />

� Neonatal macrosomia<br />

� Perpetuating cycle <strong>of</strong> increasing obesity, insulin<br />

resistance and abnormal lipid metabolism


Relationship <strong>of</strong> GDM and T2D<br />

� Parallels in inheritance features and increase<br />

in lifetime risk for T2D after GDM suggests<br />

probable common variants in genes<br />

predisposing to both


<strong>Genetics</strong> <strong>of</strong> Common<br />

Disorders<br />

� Key research effort at present<br />

� <strong>Diabetes</strong> high on priorities <strong>of</strong> studies<br />

� Research to investigate<br />

� Complications<br />

� Pharmacogenetics<br />

� Environmental triggers<br />

� Etiologic factors


Suggested references<br />

� Robitaille, J and Grant AM. The genetics <strong>of</strong><br />

gestational diabetes mellitus. Genet Med<br />

2008, 10(4):240-250<br />

� Permutt MA, Wasson J, and Cox N. Genetic<br />

epidemiology <strong>of</strong> diabetes. J Clin Invest,<br />

2005, 115(6): 1431-1439.<br />

� Newell AM. <strong>Genetics</strong> for targeting disease<br />

prevention: diabetes. Primary Care: Clinics in<br />

Office Practice 2004, 31(3)


Jeans or Genes?<br />

� Genes In Jeans!

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!